| Names | |
|---|---|
| Preferred IUPAC name | (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate |
| Other names | Levocarnitine Carnitine Vitamin Bt |
| Pronunciation | /ɛlˈkɑːr.nɪˌtiːn/ |
| Identifiers | |
| CAS Number | 541-15-1 |
| Beilstein Reference | 1907938 |
| ChEBI | CHEBI:17355 |
| ChEMBL | CHEMBL580 |
| ChemSpider | 54670 |
| DrugBank | DB00716 |
| ECHA InfoCard | ECHA InfoCard: 100.036.231 |
| EC Number | 1.1.1.108 |
| Gmelin Reference | 42104 |
| KEGG | C00318 |
| MeSH | D016015 |
| PubChem CID | 1080 |
| RTECS number | OY2625000 |
| UNII | F0VM7KU40T |
| UN number | Not regulated |
| Properties | |
| Chemical formula | C7H15NO3 |
| Molar mass | 161.20 g/mol |
| Appearance | White crystalline powder |
| Odor | Characteristic |
| Density | 1.14 g/cm3 |
| Solubility in water | Freely soluble |
| log P | -5.44 |
| Acidity (pKa) | pKa = 3.8 |
| Basicity (pKb) | pKb = 12.2 |
| Magnetic susceptibility (χ) | -5.8×10⁻⁷ |
| Refractive index (nD) | 1.521 |
| Dipole moment | 5.5216 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 210.6 J·K⁻¹·mol⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -699.7 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3595 kJ/mol |
| Pharmacology | |
| ATC code | A16AA01 |
| Hazards | |
| Main hazards | May cause eye irritation. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | Lactose Free, Gluten Free, Vegan, Sugar Free |
| Signal word | Warning |
| Hazard statements | Hazard statements: Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008. |
| Precautionary statements | Store in a cool, dry place. Keep out of reach of children. Consult your healthcare professional before use if you are pregnant, nursing, taking medication, or have a medical condition. Do not exceed recommended dosage. |
| NFPA 704 (fire diamond) | 1-0-0 |
| LD50 (median dose) | LD50: 5000 mg/kg (rat, oral) |
| PEL (Permissible) | Not regulated |
| REL (Recommended) | 500–2,000 mg per day |
| IDLH (Immediate danger) | Not listed. |
| Related compounds | |
| Related compounds | Carnitine Acetylcarnitine Propionyl-L-carnitine Gamma-butyrobetaine Betaine |
| Property | Description / Manufacturer Commentary |
|---|---|
| Product Name & IUPAC Name |
Product Name: L-Carnitine IUPAC Name: (R)-3-Carboxy-2-(trimethylazaniumyl)propanoate In industrial manufacturing, labeling must match regulatory requirements for feed, food, or pharmaceutical supply chains. The precise IUPAC name is referenced during technical transfer between production, QC, and regulatory filing. |
| Chemical Formula |
C7H15NO3 Formula verification in production relies on validated analytical methods. Structural confirmation is a batch release requirement, especially for food and pharma grades. |
| Synonyms & Trade Names |
Common Synonyms: Levocarnitine, Vitamin Bt Various synonyms are used in supply agreements and regulatory filings. Trade names and standard abbreviations sometimes differ by region or product application segment, requiring clear traceability on manufacturing and shipping documents. |
| HS Code & Customs Classification |
HS Code: 2923.90 Customs declaration requires accurate classification for import/export compliance. The selected code is based on the specific molecular structure and level of chemical transformation per harmonized tariff schedules. Key for ensuring regulatory alignment in target export markets. |
Manufacturing L-Carnitine typically selects raw materials based on cost, purity profile, and predictable supply. Betaine, lysine, or 3-chloropropionic acid serve as frequent starting materials, with route selection focusing on contamination risks and downstream purification complexity.
Critical control points target byproduct formation, racemization, and residual solvent content. Batch consistency relies on validated synthesis, controlled crystallization, and efficient chromatographic or ion-exchange purification steps. Impurity carryover is primarily monitored via HPLC and chiral assays; grade requirements for food, feed, or pharmaceutical end-use dictate how tightly impurity levels are set at batch release.
Release criteria depend on customer specification and intended application. Food and feed grades tolerate a wider range of impurity profiles, provided total carnitine and heavy metal content remain within preset internal and/or regulatory limits. Pharmaceutical grades frequently demand quantified residual solvent, low water content, and proven optical purity, all confirmed under ICH or region-specific guidance.
Handling and storage recommendations differ by grade and packaging size. Moisture content and bulk flow properties vary with processing steps. Some customers require desiccant-packed containers or nitrogen blanketing; handling in formulation depends on end-use processing conditions.
L-Carnitine is produced industrially as a crystalline solid, typically fine or granular, with a white to near-white color grade. Odor profile is neutral, and sensory deviation may suggest contamination or degradation. Production batches show melting point variance based on moisture and particle size—anhydrous forms show higher melting ranges than monohydrates. Melting point and bulk density both depend on grade, drying method, and post-processing. Boiling and flash points are not practical for operational relevance, as decomposition precedes phase change in standard processing environments.
L-Carnitine maintains chemical stability under ambient warehouse conditions but can experience hydrolysis and degradation with prolonged exposure to heat or alkalinity. Process streams require temperature monitoring to avoid decomposition and racemization, especially during drying and solution preparation. Premature browning or odor development in bulk or processed solution may signal reactivity concerns, often traceable to raw material or in-process contamination.
As a zwitterionic compound, solubility in water varies strongly with pH and temperature. Food and pharma solution batches dissolve rapidly in cold, neutral to slightly acidic water. Strong acids or bases introduce risk of racemization or off-odor. Solubility in organic solvents is low and rarely relevant to standard downstream use. Industrial preparation relies on controlled water quality and agitation speed to minimize undissolved fines, with batch filtrate clarity monitored as a real-time check.
Purity, moisture, heavy metals, and specific optical rotation define grade. Food, nutritional, and pharmaceutical specifications differ by region and customer requirement. Reference values are always batch-certified and supplied in COA. Higher grades (USP, EP, JP) undergo additional impurity scrutiny and tighter moisture control due to application niches.
Impurity classes such as D-Carnitine, inorganic salts, ammonia residuals, and reaction by-products require consistent monitoring during final purification and drying. Impurity limits are not universal—release criteria reflect region, grade, and final use (nutritional vs. API). Trace-level analysis includes enantiomeric purity, high-performance liquid chromatography (HPLC), and occasionally specific migration limits for downstream processing (e.g., infant formula).
HPLC, polarimetry, and residue-on-ignition are commonly utilized methods. Analytical protocols differ whether the target market is nutritional, pharmaceutical, or veterinary. International standards, such as USP-NF and EP monographs, are referenced for pharmaceutical releases, with internal standards supporting batch-to-batch reproducibility for food or feed applications.
Primary feedstocks include trimethylamine, β-hydroxybutyric acid derivatives, and reliable chiral precursors. Sourcing focuses on traceability and impurity load minimization; food and pharma grades demand certified, contaminant-controlled suppliers. Raw material performance is assessed by reactivity and by-product risk.
Common industrial synthesis routes include chemical resolution of racemic carnitine or direct asymmetric catalysis. Selection depends on cost, target impurity profile, and scale. For high-purity routes, enzymatic or fermentation-based methods are considered to deliver superior optical purity and sustainability.
Reaction vessel type, dosing precision, and temperature ramp tightly control enantiomeric purity and minimize side-product formation. Neutralization and pH adjustment are key points for batch reproducibility. Multiple crystallizations, filtration, and activated carbon treatments are routinely applied for pharmaceutical- and food-grade batches. Color and clarity in final product solution are used as in-process quality checkpoints.
Every lot is tested for appearance, assay, moisture, solubility, pH (in 2% solution), and enantiomeric excess. Additional release parameters may include microbial, heavy metal, and solvent residues as defined by the receiving market’s regulation. Certificates of Analysis record all critical-to-quality parameters, with release contingent on full panel compliance.
L-Carnitine can undergo esterification under acid-catalyzed conditions, giving rise to short- and medium-chain esters. Reactivity at the alcohol group allows modification to form derivatives (e.g., acetyl-L-carnitine). Downstream customization is guided by permissible reaction profiles which vary by sector (food, pharma, veterinary).
Process conditions for typical modifications rely on acid catalysts, controlled temperature, and anhydrous solvent systems. Excessive heat, high pH, or unintended metal catalysis can trigger racemization, so these parameters remain tightly controlled in all industrial scenarios.
Manufacture includes acetyl-L-carnitine and propionyl-L-carnitine, tailored through selective acylation. Each derivative batch is routinely analyzed for unreacted starting material, positional isomers, and residual solvents before downstream integration.
Product stability tracks with avoidance of humidity, excess heat, and direct sunlight. Sealed drums or vacuum packs are routine for storage and transport. Modified atmosphere packaging is used if customer requires oxygen-sensitive material.
HDPE, lined fiber drums, or stainless steel bins are compatible for bulk storage; contact with reactive metals or non-food-grade plastics is avoided to prevent leachables and moisture ingress.
Shelf life depends on grade and packaging. Degradation is marked by browning, odor, or caking. Monitoring includes regular sampling and review against set appearance criteria. Lot-specific shelf life assignment considers expiry risk and destination regulatory requirements.
L-Carnitine typically carries no major acute hazard classification under GHS for industrial grades, but actual labeling adopts region- or customer-specific requirements. Final hazard communication reflects grade purity and any trace impurities (e.g., solvents, heavy metals) introduced by process or raw material stream.
Hazard language typically refers to possible eye or respiratory irritation with excessive dust exposure, and hygiene recommendations are maintained for all granulated or powdered chemical handling.
Oral and dermal toxicity levels are low for L-Carnitine, with detailed data supplied by grade and regulatory submission status. Acute exposure risks rise only in cases of substantial impurity or residual reagent loading, usually avoidable through batch release controls.
Standard industrial procedures emphasize dust minimization, enclosure of transfer points, and use of personal protective equipment as per site SOPs. Exposure limits, if required, follow regional guidelines or are tailored to workplace assessment findings.
Production of L-Carnitine relies on the management of fermentation and chemical synthesis routes, both influenced by upstream availability of key feedstock—primarily trimethylamine, lysine, and various fermentation nutrients. Industrial-scale output fluctuates seasonally due to energy policy changes and feedstock price volatility. Plant utilization rates tend to stay optimal in regions with predictable utilities supply and well-supported biotechnology infrastructure. Inventory strategies favor consistent weekly or monthly production volume release, depending on customer contract structures and grade mix requirements.
Lead time is influenced by both production scheduling and downstream purification bottlenecks. For standard food/pharma grades, MOQ usually adapts to batch size and downstream packaging lines—smaller, custom-packaged or GMP-certified batches may extend lead times due to increased QC checkpoints. Spot orders can disrupt planned campaigns; blanket order frameworks stabilize resource allocation, especially in peak and maintenance seasons.
Packaging depends on grade and intended use; bulk feed grade typically ships in large fiber drums or intermediate bulk containers, while food and pharma grades employ double-lined drums, high-barrier foil bags, or HDPE containers to limit moisture ingress. Temperature and humidity controls are necessary for downstream quality retention, especially for high-purity or injection uses. For export consignments, reinforced palletization, desiccant use, and detailed labeling align with target market import regulations.
Sea freight dominates intercontinental bulk movement, with air shipment reserved for smaller, high-value lots. Contract terms (EXW, FOB, CIF) are dictated by buyer location and risk appetite. Larger contracts support milestone payments or net payments (30–60 days) upon delivery, while first transactions and small-volume buyers usually follow upfront or L/C payment. Compliance documentation, including origin certificates and batch-specific analysis, accompanies every shipment.
Feedstock costs drive the L-Carnitine pricing model, particularly the market-driven prices of fermentation substrates, intermediates, and regulatory-mandated additives. Sudden price hikes in natural gas or upstream ammonia-based intermediates ripple directly into batch cost structure. Raw material volatility links to regional disruptions, from energy rationing to shipping delays at major ports.
Seasonal demand shifts, logistical bottlenecks, droughts, and trade policy changes inject uncertainty into price trends for key substrates. Regulatory controls on environmental emissions affect the cost and availability of certain precursors, notably in countries tightening enforcement on chemical effluents. Parallel increases in compliance, such as new residue or purity standards, tend to raise production cost per ton.
Grade, purity level, and certification requirements drive L-Carnitine price tiers. Feed-grade, technical, and food/pharmaceutical grades require tailored isolation, purification, and validation. Higher-purity, injection, or certified-organic batches fetch significant price premiums due to more rigorous upstream QC, process zoning, and analytical confirmation. Packaging also contributes to unit economics: small, tamper-evident, pharma-grade packs entail higher costs versus larger bulk drums. Destination-specific compliance—Halal, Kosher, allergen declarations, traceability—creates another layer of cost disparity.
China, Western Europe, and the US anchor the bulk of L-Carnitine manufacturing. Most international supply flows from these clusters to growing end-user bases in nutraceuticals, animal feed, and functional foods. Short-term demand spikes tend to follow shifts in regulatory rulings or large-scale procurement cycles by multinational nutrition companies. Availability outside major clusters depends on contract imports and stockpiling strategies.
| Region | Supply Pattern | Key Price Drivers |
|---|---|---|
| US | Robust local and import supply, strict cGMP enforcement | Certification, transportation overhead, currency fluctuation |
| EU | Import-reliant with some local production | Pesticide residue, labeling, environmental compliance |
| JP | Mainly import, premium on traceability and testing | Quality documentation, purity grading cost |
| IN | Expanding domestic production, import supplement | Energy cost, plant-scale variations, local regulations |
| CN | World’s core supply base | Utility rates, feedstock costs, export control |
Oversupply risk remains contained due to growing feed and food industry requirements. Lead supply-side risks include ongoing environmental clampdowns in China, volatility in feedstock pricing, and evolving pharma/food additive regulations in Europe and North America. Price softening is unlikely without a step change in process efficiency or a major new synthesis route, both of which require verified, industrial-data-backed breakthroughs. Any new trade restrictions on chemical intermediates will directly tighten availability and amplify delivered price.
Production data and trade flow statistics reflect official industry association releases, international customs analytics, and regional price tracking. Batch pricing analysis is grounded in real transaction data (where available) and confidential supplier disclosures. Updates adhere to published regulatory statements and sector-wide technical conference summaries.
Recent supply has weathered disruptions from tighter environmental controls in key Asian regions, leading to temporary reductions in output. Consolidations among medium-scale factories have bolstered capacity utilization but raised barriers for spot buyers seeking custom or low-volume lots.
GMP and FSSC 22000 certification requirements continue to tighten across food and pharma supply chains, accelerating capital investments in upgrading existing plant zones, contaminant monitoring systems, and real-time batch tracking. New labeling and traceability rules in the EU and North America require significant expansion of documentation, challenging smaller, less integrated producers.
Diversified sourcing of key fermentation intermediates, as well as locked-in supply contracts for packaging and analytical validation, underpin mitigation strategies. Continuous process improvement goals now focus on lowering energy intensity, reducing batch-to-batch impurity variability, and accelerating compliance turnaround. R&D teams increasingly work alongside technical customer support to document new requirements and preempt certification delays.
L-Carnitine serves critical roles in performance nutrition, food fortification, and pharmaceutical formulations. Its primary purpose is to promote the transport of long-chain fatty acids into mitochondria for energy production. Applications extend across dietary supplement manufacturing, functional beverages, infant formula, animal nutrition, and injectable drug preparations.
| Industry | Common Grade(s) | Key Parameters |
|---|---|---|
| Dietary Supplements | Food grade, Pharma grade | Purity (≥98% typical), heavy metals, microbial limits, flowability |
| Infant Formula | Infant/food grade | Low residual solvents, controlled impurities, microbial controls as per region |
| Injectable Formulations | Pharma grade | Sterility, endotoxin levels, injection suitability, residual solvent content |
| Animal Nutrition | Feed grade | Assay by established method, residual solvents, feed safety standards |
| Functional Foods & Beverages | Food or beverage grade | Solubility, color stability, sensory profile |
Dietary supplement producers focus on both purity and taste profile, as off-flavors in direct-serve powders negatively affect consumer acceptance. In infant formula, quality scrutiny extends to trace levels of potential contaminants, aligning with global regulatory frameworks. Injection preparations demand the highest levels of purity and control over microbial contamination; release criteria involve validated in-house or pharmacopeial methods. Feed additives tolerate slightly higher impurity levels, but batch-to-batch consistency remains necessary due to dosing uniformity in premix applications. Beverage and food fortification benefit from grades offering easy dissolution and minimal effect on color or flavor within the application matrix.
Identify the end use—whether for dietary supplement, pharmaceutical, infant formula, functional beverage, or animal feed. Each sector maintains different standards for what constitutes an acceptable product in terms of both chemical composition and safety.
Review applicable regional and application-specific regulations: food additive codes, pharmacopeial monographs, infant formula directives, or feed safety authorities. The final grade must conform to local and destination market rules. Some markets require both product and site-specific documentation.
Check the specified assay range, impurity tolerances, and whether requirements include tests for enantiomeric purity, residual solvents, or specific contaminants like dioxins or heavy metals. Higher-purity pharma grades undergo more layers of chromatography, filtration, and testing. Food and infant formula grades apply stricter controls on peroxide value and color.
Higher grades come at a premium due to more intensive purification steps, smaller batch sizes, and extended analytical regimes. Food and feed sectors often process at larger scale, enabling cost advantages relative to tailor-made pharma lots. Quantify the impact of grade on both the formulation cost and the cumulative risk in downstream manufacturing steps.
Prior to firm procurement, request a representative sample of the proposed grade for application-specific trials. Validate critical properties such as solubility, organoleptic attributes, impurity profile, and processing behavior under your own manufacturing conditions. Supplier-issued certificates should include batch-specific results.
Procurement of starting materials relies on documented origin, established purity, and absence of genotoxic or prohibited substances. Any deviation at the raw material stage can directly impact the impurity profile of the final L-Carnitine batch.
Biosynthetic, chemical, or fermentation routes influence impurity spectra and scalability. Each approach generates unique by-products, which dictates the subsequent purification scheme. Route selection considers final assay targets, regulatory compliance, and availability of utilities.
In-process controls include pH management, temperature uniformity, and reaction time monitoring. Deviations here drive either reprocessing or, in some cases, batch rejection. Final drying and grinding steps receive special focus to prevent cross-contamination and ensure appropriate particle size for each application.
Unreacted raw materials, side products, and degradation products originate primarily from incomplete reactions or uncontrolled process conditions. These are monitored at each major process stage, often before and after primary purification.
Purification depends on the application: multiple crystallizations, activated carbon treatment, and fine filtration remove major and trace-level contaminants. The number of purification cycles is tuned to application requirements, with pharmaceutical grades passing through more extensive clean-up and end-testing.
Critical parameters include solution clarity, intermediate purity by chromatography, microbial testing, and moisture level. Tight control at this stage maintains consistent batch performance, which is crucial for regulated end uses such as injectables.
Retention of reference samples from each batch allows for retrospective quality audits. Statistical process control tools support identification and minimization of variation across campaigns. Out-of-trend findings trigger investigation and corrective actions adapted for continuous or batch processes.
Each L-Carnitine lot receives a certificate of analysis based on internal and external testing protocols. For pharma applications, release is contingent on meeting not just compositional targets but also microbiological and endotoxin limits, with fully traceable documentation for auditability.
Every lot of L-Carnitine produced within our facilities passes through a layered management system incorporating documented GMP protocols and long-established ISO standards. For food, pharmaceutical, and feed grades, ongoing compliance audits guide our team to continuously monitor not only product profiles but also systems performance. Dedicated quality control personnel oversee every production step, from receipt of core raw materials to final release, using standardized SOPs. This reduces batch variability and supports traceability, which is a primary expectation among customers in regulated markets.
Certification requirements arise from the targeted application for each L-Carnitine grade. For example, food and pharma grades follow dossiers prepared in alignment with regional regulatory bodies such as USP, EP, or JP. Certificates of Analysis and supporting documentation are issued in response to customer specifications, which often detail required purity, residual solvent profile, and microbiological status. For animal nutrition and feed applications, FAMI-QS or equivalent certification frameworks define quality protocols, with critical data captured in batch release records. Each certificate is drawn from direct QC analysis, never outsourced documentation.
Supplying accurate documentation is a core manufacturer responsibility. Each shipment receives batch-linked Certificates of Analysis listing target and achieved values for identifiable parameters such as assay, appearance, heavy metals, and solvent residues. Full product dossiers—including method validation and analytical protocols—are available to audited partners or upon direct regulatory request. Technical staff are trained to interpret and explain the data behind every lot, supporting customer validation and broader compliance reviews as required by health authorities or end-user audits.
Reliable supply stems from a scaled approach to production scheduling. Multi-line capacity allows us to allocate campaigns by contract volume, grade specification, and lead time risk. During periods of demand fluctuation, core tank inventory is reserved for critical supply contracts. Customers with annual volume commitments may access priority allocation guarantees, but every agreement is shaped by mutual forecast sharing and open lead-time communication.
The backbone of stable supply is plant redundancy and forward-planned maintenance. Our L-Carnitine process routes leverage raw material qualification frameworks, which exclude sources with recurring quality or logistics issues. Preventive maintenance routines are aligned with campaign schedules to prevent unplanned downtime. Where a customer specifies unique purity or processing requirements, dedicated production windows or isolated vessels are deployed, supporting separation from general-purpose output and minimizing cross-batch risk.
Requests for samples follow a technical qualification route. Prospective partners submit grade requirements, regulatory targets, and intended application details. Technical staff review sample needs against available inventory for both standard and custom grades. Shipping quantity, analytical documentation, and timelines are coordinated individually. Feedback from sample evaluation is directed to our R&D and QC teams to fine-tune future production runs or adjust documentation to meet customer-specific regulatory reviews.
Long-term business grows from contracts tailored to both predictable and evolving customer needs. For some, blanket order releases or consignment models minimize inventory stress on the buyer’s side. Others prefer spot-based negotiations with transparent price mechanisms linked to raw material swings. In custom formulation or direct integration, our process team works with technical liaisons on the customer side to adjust packaging, labeling, and documentation flow. Every procurement mode—annual, quarterly, or by project batch—receives support from both production planning and customer service teams, ensuring communication gaps are closed before supply risks emerge.
Our R&D team tracks two main directions: process innovation to reduce raw material wastage and impurity content, and development of high-bioavailability L-Carnitine formulations. Improvements in chiral separation and microbial synthesis are repeatedly assessed for scale-up feasibility. Electrochemical and enzymatic routes occasionally appear in pilot projects, though most full-scale plants still rely on traditional chemical synthesis due to supply chain control and batch consistency.
Application research focuses on health nutrition, clinical nutrition, and animal feed. In pharmaceutical and sports nutrition, requests now increasingly cite improved taste, solubility, and specific granule size ranges. In animal nutrition, low-odor and stabilized powder grades are in discussion. Application-flavored grades require process adjustments to accommodate masking agents or anti-caking additives. These product development tracks often demand dedicated equipment cleaning validation and real-time monitoring of formulation homogeneity.
Byproduct control and batch-to-batch purity consistency remain key challenges. Impurity profiles arise from incomplete reaction or side products during synthesis. Consistent color and odor for consumer-grade products require controlled drying and packaging; otherwise, minor degradation generates off-notes. Recent advances in continuous process monitoring have let us improve in-process adjustments, minimizing off-spec material generation. Logistic-scale membrane separation and high-throughput chromatography offer promise at the pilot plant level, though cost-benefit remains debated for full scale.
From the plant perspective, demand for L-Carnitine raw and specialty blends is projected to see steady growth in health supplement and clinical use regions. Local regulatory trends in labeling and allowable claims remain a primary driver for product differentiation and grade adjustments. Customers increasingly require detailed supply chain traceability and confirmed absence of animal derivatives or certain reactant classes, influencing raw material sourcing and certification procedures.
Anticipated future manufacturing includes more modularized facilities to enable fast-grade switching and customer-specific batch runs. We are exploring automation in real-time impurity monitoring and product-specific packaging. Cross-contamination avoidance, especially in multi-purpose plants, will steer investment in closed transfer and automated cleaning systems. Sensor-driven feedback control is being developed internally to address customer requests for narrower purity and physical property windows.
Sustainability initiatives focus on solvent recycling, energy integration across process units, and minimizing aqueous waste. Sourcing of raw feedstock from vetted and renewable routes is under ongoing supplier audit. Any new synthesis route under consideration must demonstrate both process safety and waste minimization, including minimization of chlorinated solvent use and recoverability of auxiliary agents. Energy-efficient crystallization and water use reduction are practical focus areas in facility upgrade roadmaps.
Technical requests typically range from clarification of batch release criteria to upscaling application-specific use cases. Our support staff draws on plant-side stability and compatibility testing data to advise on best-use practices. Where customer processes require grade deviation, our technical documentation details the effect of key physical and chemical properties (e.g., moisture content, particle size).
Fact-based support includes compatibility insights for premix manufacturing, advice on blending protocols, and troubleshooting for observed changes in physical appearance during downstream processing. For aqueous formulations, stability data from our internal product library supports validation runs. Application engineers consult directly with customer QC and production to identify specific points where process parameters might require adjustment. Grade selection guidance is made using data on particle flow, compressibility, or reactivity under customer process conditions.
Customer claims or deviation investigations are tracked using retained samples and full batch production records. Any out-of-spec report is evaluated for both shipping and internal process hand-off contributors. Ongoing batch consistency and traceability are supported with document packages aligning with finished product lot numbers. For customers requiring regular audits, we maintain production logs, process deviation reports, and integrated corrective action response protocols. Commitment to reproducibility and rapid response is supported by cross-departmental review of both in-market feedback and internal trend monitoring data.
As a dedicated manufacturer of L-Carnitine, years of process control and continuous plant investment have allowed us to offer consistency in large-scale production. Industry clients in animal nutrition, functional food, sports supplements, and pharmaceutical intermediates depend on stable L-Carnitine supply, not just for volume but for predictable performance in their own finished products. Manufacturing at this scale means closely managing every critical variable, from raw material qualification to in-line testing and validated batch records.
Our L-Carnitine supports key sectors with direct application in feed formulations, specialized dietary blends, and as a metabolic support ingredient in finished foods and pharma. In livestock feed, nutrition experts select L-Carnitine because it is well-characterized for aiding fatty acid metabolism and supporting growth performance. Nutrition product developers also formulate with L-Carnitine in meal replacements, bars, and energy drinks, where stability and solubility decide shelf life and brand reputation. Pharmaceutical companies require L-Carnitine for API synthesis and must meet precise impurity thresholds for registration purposes. Regular customer audits confirm our control of cross-contamination, traceability, and compliance to strict industrial requirements.
In manufacturing, process repeatability matters as much as raw purity. Every batch undergoes full-spectrum lab analysis using HPLC and microbiological testing to validate compliance to agreed specifications. Our team operates with robust in-process sampling and monitored reaction parameters. This reduces batch-to-batch deviation and allows technical teams at customer sites to forecast their own outcomes reliably. Routine audits and external certifications support risk management for public and private partners operating in regions with varying regulatory expectations.
Large-scale manufacturing enables flexible L-Carnitine packaging. Customers place bulk orders for fiber drums, intermediate bulk containers, or FIBCs, shipped under temperature-controlled conditions to protect product integrity. Full documentation, from loading photographs to real-time tracking updates, supports regulated industries where chain-of-custody and arrival condition make a clear difference. Our global logistics partnerships help companies meet their own timetables, seasonality, and project launch windows cost-effectively.
Technical experts engage with plant-level questions, ranging from formulation compatibility to usage optimization in finished matrices. Collaborations between customer R&D and our technical staff address solubility, stability, and blending procedures. For product development and scale-up phases, we provide not just detailed CoAs, but also pilot samples and in-person assessment. Performance in your factory environment forms the main criteria for our quality approach—not just meeting a generic test method.
Direct engagement with manufacturing teams shortens response time in formulation changes or regulatory shifts. Supply chain managers and procurement teams value predictable timelines for both price quotes and delivery dates. As industry priorities evolve—from compliance requirements to ESG mandates—our production site adapts with transparent documentation and compliance support. End-to-end visibility, product stewardship, and reliable delivery build a foundation for industrial buyers to plan new product rollouts and contract manufacturing runs more confidently. By providing technical documentation and analytical support, we ensure each sector receives a tailored solution based on actual production data, not marketing claims. Our focus remains on producing L-Carnitine at scale, with clarity, control, and an understanding of commercial realities faced by B2B partners worldwide.
We produce L-Carnitine with a focus on functional delivery to support nutritional and health applications. L-Carnitine stands out for its capacity to assist fatty acid metabolism and energy transport; its role in these processes relies on effective absorption. The bioavailability of our L-Carnitine stems from its hygroscopic crystalline form, which dissolves swiftly in water and is readily absorbed in the small intestine.
Many years of process refinement have shown that product form and particle size can influence absorption rates during end-use. Our technical team maintains stringent control over particle morphology and purity at each step. This attention ensures the finished product delivers on both solubility and uptake once incorporated into food, beverage, and supplement formulas. From a factory-floor perspective, handling L-Carnitine calls for close humidity monitoring; its inherent moisture attraction must not interfere with downstream blending or encapsulation processes. We address this by keeping relative humidity low throughout milling, packaging, and bag sealing.
Stability always remains a core focus through both production and logistics. L-Carnitine by its chemical nature is sensitive to moisture. It can take in water from the air, which may cause clumping or hydrolysis over time. We counteract this by employing multilayered packaging, integrating high-barrier inner liners to minimize moisture ingress. Standard 25-kilogram drums or bags are filled, flushed with inert gas, then sealed immediately after lot release.
Our operating data show that under recommended storage—dry, below 25°C, away from direct sunlight—L-Carnitine maintains its analyzed purity for well over two years. Regular stability sampling supports these numbers. We retain batch samples in warehouse conditions and periodically run assays on L-carnitine content, appearance, and potential impurities. If temperature or humidity rises beyond set points, experience teaches that the rate of degradation increases. The product may yellow, produce an odor, or show a shift in pH. We work with partners on storage environment audits and encourage only opening original drums right before final blending or tableting.
Granulated or powdered L-Carnitine endures typical commercial processing—blending, tableting, beverage formulation—without significant loss. Short exposure to moderate heat does not impact quality, but extended heat or direct steam can prompt hydrolysis or color change. That is why our lines blend at room temperature and always shield the product from unnecessary moisture. We recommend that customers who apply further processing, such as extrusion or high-shear granulation, consult with our technical support before scaling up.
Our technical specialists can support shelf-life validation studies or conduct accelerated stability checks, using real production lots. All support is rooted in first-hand knowledge from plant operations and continuous laboratory verification, removing guesswork for downstream product formulators.
From sourcing to storage, our protocols are shaped by direct factory experience and ongoing investment in analytical capabilities. We routinely share packaging guidelines, handling requirements, and best practices for compounding or beverage production, based on real-world data. Maintaining L-Carnitine stability and its effective absorption profile starts on the production floor and continues through every link of the supply chain.
We prioritize product integrity and support every customer application with full transparency on process controls and batch-tested analytical results.
As a direct L-Carnitine producer, our approach to packaging reflects both the physical characteristics of the ingredient and practical demands from major users in food, nutrition, and feed sectors. Packaging sizes stem from experience handling large-volume contracts. The bulk of global demand falls into two main options: fiber drums with inner polyethylene liners at 25 kg net weight, and intermediate flexible containers (FIBCs) typically sized for 500 kg or 1000 kg net weight. Use of FIBCs saves considerable floor space and streamlines batch dispensing in automated facilities. For projects that require smaller lots, 10 kg and 20 kg carton options offer a sensible fit, mainly for high-purity grades or custom formulations.
Through years of outbound logistics, it’s become clear that integrity and contamination safeguards matter just as much as material conservation. Our drums use food-grade liners and sealed closures. Drums and sacks stack easily for palletized storage and containerized shipping. Every closure method has been evaluated for moisture and oxygen sensitivity risks. Any customer-specific labeling, palletization configuration, or tamper-evidence request is handled directly from our plant.
Bulk synthesis, blending, and packaging processes dictate the minimum size for a material batch. Our internal thresholds reflect both economic and technical factors. The minimum order for L-Carnitine bulk shipments stands at 500 kg for unblended material. This respects the production set-up time, fiber drum costs, inspection needs, and transport efficiency. For large food and sports nutrition groups, lot sizes almost always scale from one metric ton and above per shipment. We work directly with customers’ planners to map monthly or quarterly order flows against in-house inventory targets. This approach avoids downtime or overstock.
Lead time starts with clarity—final customer order, packaging confirmation, and destination vetting. Core raw materials and equipment operate on a continuous schedule. For L-Carnitine products, lead times for standard grades and package formats run 10 to 15 business days from confirmed order to ex-works readiness. This includes sample retention, batch records, and full analytical verification. For customized blends or non-standard labeling, an extra five working days covers all additional steps.
Sometimes, demand spikes hit fast. Our operational model includes buffer inventory for major customers, which allows rapid turnaround by pulling from tagged lots. Supply disruptions can threaten just-in-time projects, so we maintain real-time inputs on raw material pipeline stability. Our team constantly works to shorten lead times through automation and predictive scheduling.
In practice, efficiency in packaging and order logistics has a direct effect on customer cost management and product shelf life. Too many unnecessary transfers or repacks increase contamination risks or product loss. From continuous process control, to on-site quality release, to documented chain-of-custody on every drum and tote, our process stands on transparency and reliability. Open communication between technical, warehousing, and sales groups keeps the pipeline flowing. We do not believe in standard answers—actual project experience has proven that a direct relationship with end-users yields both lower cost per kilo and a much lower quality deviation rate than any indirect channel could offer.
Manufacturing L-Carnitine for global markets demands a clear grasp of both local and international regulations. We encounter customs controls, food safety agencies, and pharmaceutical boards across regions, each placing unique requirements on sourcing, processing, and transportation. In our own facilities, we build every batch with these requirements in mind because failing compliance means production stops and product cannot reach end users. Our experience teaches us that missing even a minor documentation detail at the border or at an audit will lead to lost opportunities and reputational damage. These are not theoretical risks. We have seen poorly documented shipments from less disciplined manufacturers held at ports, causing real supply disruptions.
With every production run of L-Carnitine, our technical and regulatory specialists review updates from relevant authorities, such as the US FDA, European EFSA, China's SAMR, and others. For L-Carnitine, these might include purity standards, residual solvent limits, and labeling regulations. Each market may request different documentation, whether it’s a Certificate of Analysis, GMP audit report, or Non-GMO statement. Our documentation package includes not only batch-specific test results but also process and origin certifications where needed. Over the years, we have refined our systems to track and archive these records—no scrambling for paperwork last-minute.
Customers often bring detailed checklists for import and registration. Our regulatory staff works with these requests directly, making sure our documentation matches their country’s import guidebooks. This means our export paperwork can include electronic signatures, original stamps, or multilingual labeling if required. By building documentation procedures into every shipment, we remove the friction that leads to border delays or failed audits.
End uses for L-Carnitine range from food and beverage to dietary supplements, pharmaceuticals, and veterinary formulations. Our production lines hold certifications including FSSC 22000, ISO 9001, and others recognized by authorities around the world. This enables us to meet distinct regulatory checkboxes from different customers: one customer requests Halal or Kosher, while another wants allergen-free declarations to comply with local labeling regulations. Even years after a batch leaves our plant, we can retrieve its traceability and quality records—reflecting the type of operational dedication required by experienced manufacturers dealing in regulated markets.
The import process for L-Carnitine continues to grow more challenging as governments increase health and safety oversight. We meet those expectations by investing in validated analytical instruments and third-party laboratory confirmations. Material leaving our site is sampled by trained quality teams, tested in accordance with global pharmacopoeias or food standards, and all results are documented in a manner accepted by international authorities. This keeps the process transparent and reproducible.
Direct manufacturers like us face practical questions every day from import agents, government officials, and auditors. For every inquiry—be it TSE/BSE statements, full ingredient lists, or residual solvent levels—we do not offer generalities. Our team provides itemized documentation, with batch numbers, test dates, analyst signatures, and any supporting certifications. When countries revise their regulations, we update our controls and inform our buyers so downstream users can keep their own compliance in order.
As manufacturers, it falls on us to maintain traceable records, respond quickly to requests, and design our processes around evolving global requirements. Our ability to provide thorough, up-to-date compliance documentation directly supports reliable supply chains and gives our customers confidence that their imported L-Carnitine stands up to any regulatory or quality audit, anywhere in the world.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales7@bouling-chem.com, +8615371019725 or WhatsApp: +8615371019725
